Listen time: 27m 23s

About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Visit our Heart Failure Management Hub to discover a range of educational content to facilitate the use of SGLT-2 inhibitors and other guideline directed medical therapies as foundational treatment for HF.

Articles

Global Heart Failure Burden

Published:

27 July 2023

Citation:

Cardiac Failure Review 2023;9:e11.

NICE versus ESC Guidance in Heart Failure and Cardiac Device Management

Published:

30 June 2023

Citation:

Arrhythmia & Electrophysiology Review 2023;12:e21.

Contemporary Review of the Management of LV Thrombus

Published:

27 June 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e23.

Transvenous Lead Extraction: Work in Progress

Published:

19 June 2023

Citation:

European Cardiology Review 2023;18:e44.